Cost as a Barrier to Pneumococcal Vaccination

As a healthcare provider, you know that pneumococcal vaccination saves lives. But even when you write the recommendation, cost concerns can prevent patients from following through — especially uninsured and underinsured patients who face the full cash price at the pharmacy counter.

Pneumovax 23 (pneumococcal vaccine polyvalent, Merck) costs $100–$250 per dose without insurance. For a patient already managing multiple chronic conditions and their associated medication costs, that number can be the difference between getting vaccinated and walking away.

This guide covers the savings programs, coverage pathways, and cost-conversation strategies that can help your patients access Pneumovax 23 without the financial barrier.

What Your Patients Are Paying

Understanding the cost landscape helps you guide patients more effectively:

• Cash price (no insurance): $100–$250 per dose, varying by pharmacy and region
• Medicare Part B: $0 copay — pneumococcal vaccines are covered under Part B (not Part D), with no deductible or cost-sharing
• Medicaid: Covered in most states with no cost to the patient
• Private insurance (ACA-compliant plans): $0 copay for ACIP-recommended vaccines under the preventive care mandate
• Uninsured/underinsured: Full cash price unless they access a savings program

The good news: the vast majority of your patients have some form of coverage that makes Pneumovax 23 free or very low-cost. The challenge is the patients who fall through the cracks — those without insurance, with non-ACA-compliant plans, or who don't understand their benefits.

Medicare Part B Coverage — Key Details for Providers

This is worth highlighting because it's frequently misunderstood by both patients and office staff:

• Pneumococcal vaccines are covered under Medicare Part B, not Part D
• There is no deductible and no copay for pneumococcal vaccination under Part B
• Coverage includes both the vaccine and its administration
• Providers should bill Medicare Part B directly (not route through a pharmacy benefit)
• Both Pneumovax 23 and pneumococcal conjugate vaccines (PCV15, PCV20) are covered

If your Medicare patients are being told they owe money for a pneumococcal vaccine, there may be a billing error. Ensure your billing team is coding these correctly under the Part B preventive benefit.

Manufacturer Savings Programs

Merck Vaccine Patient Assistance Program

Merck offers a patient assistance program for eligible uninsured or underinsured patients through merckhelps.com. Key details:

• Available to patients who lack insurance coverage for vaccines
• Patients must meet income eligibility requirements
• Application process can be completed online or by phone
• Vaccines are provided at no cost to qualifying patients

As a provider, you can help by identifying uninsured patients who need Pneumovax 23, informing them about the program, and assisting with the application if your practice has care coordinators or social workers.

Vaccines for Children (VFC) Program

For pediatric patients aged 2–18 who are at high risk for pneumococcal disease:

• The VFC program provides vaccines at no cost to children who are Medicaid-eligible, uninsured, underinsured, or American Indian/Alaska Native
• Enrolled providers can order VFC vaccines through their state immunization program
• If your practice serves pediatric patients, ensure you're enrolled as a VFC provider

Community Resources and Alternative Access Points

For patients who don't qualify for manufacturer programs or need immediate access:

• Federally Qualified Health Centers (FQHCs): Provide vaccinations on a sliding-fee scale based on income. Direct patients to findahealthcenter.hrsa.gov to locate one nearby.
• Local and county health departments: Many offer adult immunizations at low or no cost, particularly for pneumococcal and influenza vaccines.
• Pharmacy vaccination programs: Major chains (CVS, Walgreens, Walmart) sometimes run promotional pricing on vaccines or participate in manufacturer discount programs. Patients can also use discount cards to reduce costs.

Discount and Coupon Cards

While Pneumovax 23 isn't a traditional prescription medication, some discount card platforms do list vaccine pricing:

• GoodRx — May show pricing at participating pharmacies
• SingleCare — Can provide discounted rates at some locations
• RxSaver — Another option for comparing pharmacy prices

These can help uninsured patients reduce their out-of-pocket cost, though savings vary. Encourage patients to compare prices across multiple pharmacies, as vaccine pricing can differ significantly — sometimes by $50 or more between nearby locations.

For a comprehensive patient-facing guide to savings options, refer patients to our article: How to Save Money on Pneumovax 23.

Therapeutic Alternatives to Consider

In some cases, the best way to address cost concerns is to consider whether a different pneumococcal vaccine might be more appropriate — or more accessible — for a given patient:

• Prevnar 20 (PCV20): A single-dose pneumococcal conjugate vaccine covering 20 serotypes. For adults who haven't previously received a pneumococcal conjugate vaccine, PCV20 alone may provide adequate protection without needing a follow-up PPSV23 dose. This simplifies the vaccination schedule and may reduce overall cost if PPSV23 is hard to access.
• Vaxneuvance (PCV15) + Pneumovax 23: The two-dose sequence recommended by ACIP. If PCV15 is more readily available or covered differently by a patient's plan, this may be preferable.

For a detailed comparison of alternatives, see: Alternatives to Pneumovax 23.

When Pneumovax 23 is specifically indicated (e.g., to complement a prior PCV15 dose or for revaccination in high-risk patients), substitution may not be appropriate. Use clinical judgment and consult current ACIP guidelines.

Addressing Supply Constraints

Pneumovax 23 has experienced intermittent supply constraints that can compound cost issues — when a patient's usual pharmacy is out of stock, they may end up at a higher-priced location or delay vaccination entirely.

To help your patients navigate availability:

• Use Medfinder for Providers to check real-time stock at nearby pharmacies
• Consider stocking Pneumovax 23 in your practice if you administer vaccines frequently — this gives you control over both availability and billing
• For more strategies, see our provider guide: How to Help Your Patients Find Pneumovax 23 in Stock

Building Cost Conversations Into Your Workflow

Many providers hesitate to discuss cost, but research consistently shows that cost is a leading barrier to medication and vaccine adherence. Here are practical ways to integrate cost conversations:

1. Ask About Insurance Status

Before recommending Pneumovax 23, briefly confirm the patient's coverage: "Do you have insurance that covers vaccines?" This takes 10 seconds and tells you immediately whether cost will be an issue.

2. Lead With the Good News

For insured patients, start with: "The good news is this vaccine is covered by your insurance at no cost to you." For Medicare patients specifically: "Medicare Part B covers this vaccine completely — no copay, no deductible." Patients are more likely to accept vaccination when they know it's free.

3. Have a Savings Workflow for Uninsured Patients

When you identify an uninsured patient who needs Pneumovax 23, have a standard process:

1. Check if your practice can administer it and bill at a reduced self-pay rate
2. Offer information about the Merck Patient Assistance Program (merckhelps.com)
3. Refer to a local FQHC or health department if your practice can't accommodate them
4. Provide the patient with resources to compare pharmacy prices (Medfinder, GoodRx)

4. Document and Follow Up

If a patient declines vaccination due to cost, document it and flag for follow-up. Circumstances change — they may gain insurance, become eligible for a program, or find a lower-cost option. A patient who says no today may say yes in three months with the right support.

5. Empower Your Staff

Front desk and nursing staff are often the first to hear cost concerns. Train them to recognize these conversations and provide basic information about coverage and savings programs. A laminated quick-reference card with key facts ("Medicare Part B = $0 copay," "merckhelps.com for uninsured patients") can be extremely helpful.

Final Thoughts

Pneumococcal disease is preventable, and cost should never be the reason a patient goes unvaccinated. For the majority of your patients, Pneumovax 23 is covered at no cost through Medicare, Medicaid, or private insurance. For those without adequate coverage, manufacturer programs, community health centers, and discount tools can bridge the gap.

By building brief cost conversations into your vaccination workflow, you can catch financial barriers early and connect patients with the right resources before they leave your office. It takes minimal time and can make the difference between a patient who gets vaccinated and one who doesn't.

For real-time Pneumovax 23 availability and provider tools, visit Medfinder for Providers.